Sharps Technology, Inc. (NASDAQ:STSS) Short Interest Update

Sharps Technology, Inc. (NASDAQ:STSS) was the recipient of a significant drop in short interest in the month of November. As of November 30th, there was short interest totalling 40,800 shares, a drop of 32.0% from the November 15th total of 60,000 shares. Currently, 2.3% of the shares of the company are sold short. Based on an average daily volume of 185,800 shares, the days-to-cover ratio is presently 0.2 days.

Institutional Inflows and Outflows

A hedge fund recently bought a new stake in Sharps Technology stock. Garden State Investment Advisory Services LLC acquired a new position in shares of Sharps Technology, Inc. (NASDAQ:STSS) in the 3rd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund acquired 172,909 shares of the company’s stock, valued at approximately $26,000. Garden State Investment Advisory Services LLC owned about 9.61% of Sharps Technology at the end of the most recent quarter. 17.17% of the stock is currently owned by institutional investors and hedge funds.

Sharps Technology Stock Up 2.5 %

Shares of STSS traded up $0.05 during mid-day trading on Friday, reaching $2.04. The company had a trading volume of 99,088 shares, compared to its average volume of 209,400. The stock’s 50-day moving average price is $2.83. The stock has a market cap of $3.67 million, a P/E ratio of -0.25 and a beta of 1.37. Sharps Technology has a twelve month low of $1.70 and a twelve month high of $18.15.

About Sharps Technology

Sharps Technology, Inc, a medical device company, researches, designs, develops, manufactures, distributes, and sells safety syringe products in the United States. It offers Sharps Provensa, an ultra-low waste space syringe for the administration of various vaccines and injectable medications. Sharps Technology, Inc was incorporated in 2017 and is based in Melville, New York.